Zentalis Pharmaceuticals: Strong Leadership and Promising Clinical Developments Justify Buy ...
TD Cowen analyst Tyler Van Buren has maintained their bullish stance on ZNTL stock, giving a Buy rating today. Tyler Van Buren has given his ...